Burning Rock Biotech (Burning Rock Biotech) Other Long-Term Liabilities : $0.66 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Burning Rock Biotech Other Long-Term Liabilities?

Burning Rock Biotech's other long-term liabilities for the quarter that ended in Mar. 2024 was $0.66 Mil.

Burning Rock Biotech's quarterly other long-term liabilities increased from Sep. 2023 ($0.48 Mil) to Dec. 2023 ($0.64 Mil) and increased from Dec. 2023 ($0.64 Mil) to Mar. 2024 ($0.66 Mil).

Burning Rock Biotech's annual other long-term liabilities declined from Dec. 2021 ($1.85 Mil) to Dec. 2022 ($0.59 Mil) but then increased from Dec. 2022 ($0.59 Mil) to Dec. 2023 ($0.64 Mil).

Burning Rock Biotech Other Long-Term Liabilities Historical Data

The historical data trend for Burning Rock Biotech's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burning Rock Biotech Other Long-Term Liabilities Chart

Burning Rock Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Burning Rock Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Burning Rock Biotech Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Burning Rock Biotech Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Burning Rock Biotech's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Burning Rock Biotech (Burning Rock Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

BNR:UK 6BUA:Germany

Address

No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005

Website

https://www.brbiotech.com

Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.